Open AccessApremilast in people living with HIV with psoriasis vulgaris: A case report
Author(s) -
Bela Shah,
Deval Mistry,
Navin Chaudhary
Publication year - 2019
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_633_18
Subject(s) - apremilast , psoriasis , medicine , dermatology , human immunodeficiency virus (hiv) , immunosuppression , immunology , psoriatic arthritis
Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until now, there have been no documented case of apremilast therapy for HIV-associated psoriasis in India. Here, we report a case of HIV-associated psoriasis who achieved Psoriasis Area and Severity Index (PASI) 100 with apremilast therapy.